StreetInsider.com News Articles

Form 4 Ingevity Corp For: Jul 24 Filed by: PLATT PHILLIP JOHN

Tue, 28 Jul 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260728/26828053.html

Form 4 Ingevity Corp For: Jul 24 Filed by: PLATT PHILLIP JOHN

Tue, 28 Jul 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260728/26828053.html

Ingevity's warm-mix asphalt additive wins German federal approval

Thu, 16 Jul 2026 12:49:25 -0400

Ingevity Corporation (NYSE: NGVT) announced that its Evotherm P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt, for use in warm-mix asphalt applications.

The approval followed several years of technical evaluation, including performance testing alongside conventional hot-mix asphalt under real-world traffic and environmental conditions. BASt determined that Evotherm P35 met the durability and long-term performance criteria required for federal use in Germany.

"The BASt approval reflects how our technology aligns with the performance, environmental and regulatory priorities shaping the German market," said Dale Willis, global vice president of strategy and innovation, Pavement Technologies. "It underscores the

Ingevity’s Evotherm® P35 receives BASt approval in Germany

Thu, 16 Jul 2026 12:49:00 -0400

Approval reflects alignment with evolving regulatory and performance standard for German market requirements

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- Ingevity Corporation (NYSE:NGVT) today announced Evotherm® P35 warm-mix additive has received approval from Germany’s Federal Highway Research Institute, known as BASt, for use in warm-mix asphalt applications. Approval signals that Evotherm® P35 meets the institute’s rigorous requirements, positioning the technology for use in one of Europe’s most demanding regulatory environments.

The approval follows several years of technical evaluation, including performance testing alongside conventional hot-mix asphalt under real-world traffic and environmental conditions. Based on those results, Evotherm® P35 met the durability and long-term

Ingevity’s Evotherm® P35 receives BASt approval in Germany

Thu, 16 Jul 2026 12:49:00 -0400

Approval reflects alignment with evolving regulatory and performance standard for German market requirements

Ingevity’s Evotherm® P35 receives BASt approval in Germany

Thu, 16 Jul 2026 12:49:00 -0400

Approval reflects alignment with evolving regulatory and performance standard for German market requirements

Ingevity’s Evotherm® P35 receives BASt approval in Germany

Thu, 16 Jul 2026 12:49:00 -0400

Approval reflects alignment with evolving regulatory and performance standard for German market requirements

Form 4 Ingevity Corp For: Jul 06 Filed by: Fisher Ryan C.

Wed, 08 Jul 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260708/26748282.html

Form 4 Ingevity Corp For: Jul 06 Filed by: Fisher Ryan C.

Wed, 08 Jul 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260708/26748282.html

Form 4 Ingevity Corp For: Jul 01 Filed by: WILLIS J KEVIN

Thu, 02 Jul 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260702/26728220.html

Form 4 Ingevity Corp For: Jul 01 Filed by: WILLIS J KEVIN

Thu, 02 Jul 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260702/26728220.html

Form 4 Ingevity Corp For: Jul 01 Filed by: Segal Francis David

Thu, 02 Jul 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260702/26728163.html

Form 4 Ingevity Corp For: Jul 01 Filed by: Segal Francis David

Thu, 02 Jul 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260702/26728163.html

Ingevity announces dates for second quarter 2026 earnings release and webcast

Thu, 02 Jul 2026 06:00:00 -0400

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- Ingevity Corporation (NYSE: NGVT) announced today that it will release its second quarter 2026 earnings after the stock market close on Wednesday, July 29, 2026.

The company will host a live webcast on Thursday, July 30, at 10:00 a.m. (Eastern) to discuss second quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity’s website.

Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 943357132. Callers outside the

Ingevity announces dates for second quarter 2026 earnings release and webcast

Thu, 02 Jul 2026 06:00:00 -0400

Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 943357132. Callers outside the

Ingevity announces dates for second quarter 2026 earnings release and webcast

Thu, 02 Jul 2026 06:00:00 -0400

Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 943357132. Callers outside the

Ingevity announces dates for second quarter 2026 earnings release and webcast

Thu, 02 Jul 2026 06:00:00 -0400

Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 943357132. Callers outside the

Form 4 Ingevity Corp For: Jun 22 Filed by: Cotterman Ryan Joseph

Wed, 24 Jun 2026 18:05:00 -0400

si-local-file:///var/storage/secattach/20260624/26686662.html

Form 4 Ingevity Corp For: Jun 22 Filed by: Cotterman Ryan Joseph

Wed, 24 Jun 2026 18:05:00 -0400

si-local-file:///var/storage/secattach/20260624/26686662.html

Form 3 Ingevity Corp For: Jun 22 Filed by: Cotterman Ryan Joseph

Wed, 24 Jun 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260624/26686582.html

Form 3 Ingevity Corp For: Jun 22 Filed by: Cotterman Ryan Joseph

Wed, 24 Jun 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260624/26686582.html

Form 8-K Ingevity Corp For: Jun 22

Wed, 24 Jun 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260624/26686231.html

Form 8-K Ingevity Corp For: Jun 22

Wed, 24 Jun 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260624/26686231.html

Dentsply Sirona names John Fortson as chief financial officer

Thu, 11 Jun 2026 08:30:13 -0400

Dentsply Sirona Inc. (NASDAQ: XRAY) announced the appointment of John Fortson as executive vice president and chief financial officer, effective July 20.

Fortson brings more than 25 years of leadership experience in finance, operations, and strategy across public and private equity-backed companies. He has served 13 years as either CFO or CEO of global manufacturing and industrial businesses.

Most recently, Fortson served as president and CFO of Kymera International, a specialty materials company backed by Palladium Equity Partners and Goldman Sachs. During his tenure, he helped lead the integration of a global platform spanning 21 manufacturing facilities across 14 countries while overseeing

Dentsply Sirona names John Fortson as chief financial officer

Thu, 11 Jun 2026 08:30:13 -0400

Dentsply Sirona Inc. (NASDAQ: XRAY) announced the appointment of John Fortson as executive vice president and chief financial officer, effective July 20.